Page 24 - 《中国药房》2024年22期
P. 24

基于 HPLC 指纹图谱和多成分含量综合评价扶正胶囊的质量
                                                                                                          Δ


                                                   1
          陈 松 ,李运容 ,农璐蔚 ,黎 丽 ,江先再 ,曾翠琼 ,王柳萍 (1.广西中医药大学附属国际壮医医院壮瑶
                                                                    2, 3 #
                                                            1
                                   1
                           1
                                           1
                 1*
          药研发中心,南宁 530201;2.广西中医药大学药学院,南宁 530200;3.广西中医药大学中药学国家级实验教
          学示范中心,南宁 530200)
          中图分类号  R917;R284.1      文献标志码  A      文章编号  1001-0408(2024)22-2726-06
          DOI  10.6039/j.issn.1001-0408.2024.22.04
          摘   要  目的  建立壮药制剂扶正胶囊指纹图谱和多指标成分含量的测定方法,并对其进行质量评价。方法  采用高效液相色谱
         (HPLC)法,结合《中药色谱指纹图谱相似度评价系统(2004A)》建立12批扶正胶囊样品的指纹图谱,并进行相似度评价、共有峰确
          认;以指纹图谱共有峰峰面积为变量,采用SPSS 20.0软件进行聚类分析和主成分分析。采用同一HPLC法测定12批样品中甘草
          苷、特女贞苷、3,6′-二芥子酰基蔗糖、甘草酸铵的含量。结果  12批扶正胶囊样品共有22个共有峰,相似度均大于0.91;指认出甘
          草苷(峰8)、特女贞苷(峰10)、3,6′-二芥子酰基蔗糖(峰11)、甘草酸铵(峰21)4个共有峰;12批样品可聚为3类,200801、200802、
          200803为Ⅰ类,样1~样8为Ⅱ类,221101为Ⅲ类;200802的综合得分(2.540)最高。12批样品中,甘草苷、特女贞苷、3,6′-二芥子
          酰基蔗糖、甘草酸铵的含量分别为0.44~0.73、1.28~2.47、0.08~0.12、1.31~1.81 mg/粒。结论  12批扶正胶囊样品的主要成分相
          似但含量有所差别,以200802的质量最优;所建指纹图谱和多指标成分含量测定方法专属性强、准确度高,结合化学模式识别分
          析可用于扶正胶囊的质量评价。
          关键词  扶正胶囊;指纹图谱;含量测定;化学模式识别分析;质量评价;高效液相色谱法

          Quality  evaluation  of  Fuzheng  capsules  based  on  HPLC  fingerprint  and  multi-ingredient  content
          determination
                                                                         1
                                                                                           1
                                                         1
          CHEN Song ,LI Yunrong ,NONG Luwei ,LI Li ,JIANG Xianzai ,ZENG Cuiqiong ,WANG Liuping
                                                  1
                                                                                                           2, 3
                      1
                                  1
         (1.  Zhuang  &  Yao  Medicine  Research  and  Development  Center,  Guangxi  International  Zhuang  Medicine
          Hospital  Affiliated  to  Guangxi  University  of  Chinese  Medicine,  Nanning  530201,  China;2.  College  of
          Pharmacy, Guangxi University of Chinese Medicine, Nanning 530200, China;3. National Demonstration Center
          for  Experimental  Chinese  Medicine  Education,  Guangxi  University  of  Chinese  Medicine,  Nanning  530200,
          China)
          ABSTRACT    OBJECTIVE  To  establish  the  fingerprint  of  the  Zhuang  medicine  preparation  Fuzheng  capsules  and  a  method  for
          the determination of multi-ingredient content for quality evaluation. METHODS  High-performance liquid chromatography (HPLC)
          was  used  in  conjunction  with  the  Similarity  Evaluation  System  for  Chromatographic  Fingerprints  of  Traditional  Chinese  Medicine
         (2004A  edition)  to  establish  the  fingerprint  of  12  batches  of  Fuzheng  capsules,  evaluate  their  similarity  and  confirm  the  common
          peaks.  Cluster  analysis  and  principal  component  analysis  were  performed  using  SPSS  20.0  software  with  the  peak  areas  of  the
          common  peaks  in  the  fingerprint  as  variables.  The  same  HPLC  method  was  adopted  to  determine  the  content  of  liquiritin,
          specnuezhenide,  3,6′-disinapoyl  sucrose  and  ammonium  glycyrrhizinate  in  the  12  batches  of  samples.  RESULTS  A  total  of  22
          common  peaks  were  identified  in  the  fingerprints  of  the  12  batches  of  Fuzheng  capsules,  with  the  similarities  greater  than  0.91.
          Four  common  peaks  were  identified  as  liquiritin (peak  8),  specnuezhenide (peak  10),  3,6′-disinapoyl  sucrose (peak  11),  and
                                                              ammonium  glycyrrhizinate  (peak  21).  The  12  batches  of

              Δ 基金项目 国家中医药管理局全国名老中医药专家传承工作室                   samples  could  be  clustered  into  3  categories,  with  200801,
          建设项目——黄汉儒全国名老中医药专家传承工作室、黄瑞松全国名                      200802 and 200803 as category Ⅰ, samples 1 to 8 as category
          老中医药专家传承工作室(No.国中医药人教函〔2022〕75号);国家卫                Ⅱ ,  and  221101  as  category  Ⅲ .  The  sample  200802  had  the
          生健康委、国家中医药管理局第二届全国名中医项目(No. 国中医药                    highest  comprehensive  score  (2.540).  The  contents  of
          人教发〔2022〕5 号);国家中医药管理局高水平中医药重点学科建设                  liquiritin,  specnuezhenide,  3, 6′-disinapoyl  sucrose  and
          项目——少数民族药学(壮药学)(No.zyyzdxk-2023165);广西中医药
                                                              ammonium  glycyrrhizinate  in  the  12  batches  of  samples  were
          大学全国名中医黄汉儒学术思想与临床诊疗传承发展推广中心项目
                                                              0.44 to 0.73, 1.28 to 2.47, 0.08 to 0.12, and 1.31 to 1.81 mg
         (No.2022V004)
             *第一作者 副主任药师。研究方向:药物分析、质量控制、民族药                   per  capsule,  respectively.  CONCLUSIONS  The  main
          制剂研发。E-mail:84946936@qq.com                         components  of  the  12  batches  of  Fuzheng  capsules  were
              # 通信作者 教授,博士。研究方向:中药、民族药的品质与药效研                 similar,  but  the  content  varied,  with  the  sample  200802
          究。E-mail:rousel@126.com                             indicating  the  highest  quality.  The  established  fingerprint  and


          · 2726 ·    China Pharmacy  2024 Vol. 35  No. 22                            中国药房  2024年第35卷第22期
   19   20   21   22   23   24   25   26   27   28   29